Evidence map›Paper›PMID 29501528›Full record

ArticleNeuropharmacology2018

Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.

Joshua S Elmore, Ann M Decker, Agnieszka Sulima, Kenner C Rice, John S Partilla, Bruce E Blough, Michael H Baumann

Abstract readComparative Study
In one paragraph

Article in Neuropharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
7.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Sublethal Concentrations of 2C-I and 25I-NBOMe Designer Drugs ImpactInternational journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Effect ofFrontiers in psychiatry · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Joshua S ElmoreDesigner Drug Research Unit, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA.
Ann M DeckerCenter for Drug Discovery, Research Triangle Institute, Research Triangle Park, NC, 27709, USA.
Agnieszka SulimaDrug Design and Synthesis Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, 20892, USA.
Kenner C RiceDrug Design and Synthesis Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, 20892, USA.
John S PartillaDesigner Drug Research Unit, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA.
Bruce E BloughCenter for Drug Discovery, Research Triangle Institute, Research Triangle Park, NC, 27709, USA.
Michael H BaumannDesigner Drug Research Unit, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA. Electronic address: mbaumann@mail.nih.gov.
National Institute on Drug Abuse · USNational Institutes of Health · USRTI International · US

Funding

Studies on MDMA and Related CompoundsZIADA000523 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI BAUMANN, MICHAEL · 2009 to 2025
$16.4M
Medicinal Chemistry of Drugs Acting on Biogenic Amine ReceptorsZIADA000532 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI RICE, KENNER · 2009 to 2020
$4.5M
IMPROVING HEALTH CARE UTILIZATION IN HIV+ DRUG USERSK23DA000523 · NIDA · JOHNS HOPKINS UNIVERSITY · PI GEBO, KELLY A · 2001 to 2005
$794k
Intramural NIH HHS ZIA DA000523NIDA NIH HHS K23 DA000523NULL ZIA DA000523-09
6 · The paper itself

Abstract

2,5-Dimethoxyphenethylamines (2C compounds) are 5-HT

Indexed as

AnimalsBack MusclesBenzylaminesBrainDimethoxyphenylethylamineDose-Response Relationship, DrugFluorobenzenesHallucinogensHead MovementsHEK293 CellsHumansMaleMolecular StructureMotor ActivityMuscle ContractionPhenethylamines2-(4-chloro-2,5-dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)ethanamine2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamineBenzylaminesDimethoxyphenylethylamineFluorobenzenesHallucinogensPhenethylaminesPiperidinesReceptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2CSerotonin Agentsvolinanserin5-HT(2A) receptorBack muscle contractionsNBOMeWet dog shakes

Identifiers

PMID29501528
PMCPMC6119551
OpenAlexW2794166569

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.